Cambridge Consultants Joins Hands with HemoSonics; New Tech to Control Blood Loss On its Way

October 16, 2012, By Sanjeev Ramachandran

Based in Virginia, HemoSonics is a name popular worldwide in the medical arena. Latest info suggests that they have agreed with Cambridge Consultants in bringing about new technology and devices that can very well alter the course of medical science.

As the latest product of their joint innovation, the upcoming device will give out critically valid and required data to guide the treatment of bleeding and blood clots in surgery, trauma and intensive care.

Named the Point-of-Care (POC) analyzer, this gadget is being designed to retrieve data regarding the four treatable systems that control clotting: platelets, coagulation factors, fibrinogen and fibrinolytic proteins.

The significance of these data are very important as disruption or imbalance of these systems causes life-threatening bleeding and blood clots, which can result in heart attack, stroke, pulmonary embolism and hemorrhage.

About 1/3rd of total deaths in the developed world are caused by these conditions. Thus this technology will aid doctors in rapidly diagnosing these disruptions, such that they can implement life-saving therapy.

The HemoSonics POC will be first used in open-heart surgery, where up to a quarter of patients will be suffering from excessive bleeding. The currently employed methods are pretty slow.

Now-a-days doctors either send blood to a lab to perform an array of tests and wait for results in the operating room or they make a best guess, without hard data, to guide treatment.

This process has been shown to waste blood products, increase costs, and worsen patient outcomes. All these problems will be mitigated once the POC is installed. With that all the required data will be available in the shortest time such that more lives can be saved.

© 2008-2012 - All rights reserved | Privacy Policy